AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2021
Jun 3, 2021
35599_dirs_2021-06-03_c58d2402-0f38-4e3f-b962-98e5b2f8a5f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2021-06-02
Reporting Person: Goel Shubh (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-02 | Stock Option (right to buy) | $7.53 | A | 100000 | Acquired | 2031-06-02 | Common Shares (100000) | Direct |
Footnotes
F1: On June 3, 2021, Fennec Pharmaceuticals, Inc. announced that Shubh Goel was granted an incentive stock option to purchase 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan. The date of the grant is June 2, 2021.
F2: 1/3 of the shares subject to this option shall vest immediately and may be exercised as of June 2, 2022 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 31, 2024 and thereafter, 100% of the total number of shares subject to this option shall be vested.